Trial Profile
A Phase 4, Single-center, Prospective, Double-blind, Placebo-controlled, Randomized Study to Investigate the Safety and Efficacy of Sodium Polystyrene Sulfonate (SPS) in Subjects With Hyperkalemia.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Zirconium silicate (Primary)
- Indications Hyperkalaemia
- Focus Therapeutic Use
- Sponsors ZS Pharma
- 30 Apr 2015 New trial record